Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event.

Yeh, I-Tien; Martin, Mathew A; Robetorye, Ryan S; Bolla, Aswani R; McCaskill, Chris; Shah, Rashmi K; Gorre, Mercedes E; Mohammed, Mansoor S; Gunn, Shelly R

Yeh, I-Tien; Martin, Mathew A; Robetorye, Ryan S; Bolla, Aswani R; McCaskill, Chris; Shah, Rashmi K; Gorre, Mercedes E; Mohammed, Mansoor S; Gunn, Shelly R.

Affiliation

Yeh IT; Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. yehi@uthscsa.edu

Mod Pathol ; 22(9): 1169-75, 2009 Sep.

Article in En | MEDLINE | ID: mdl-19448591

Subject(s)

Breast Neoplasms/genetics; Chromosomes, Human, Pair 17/genetics; Comparative Genomic Hybridization/methods; Gene Dosage; Genes, erbB-2/genetics; Chromosomes, Artificial, Bacterial; Female; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Reproducibility of Results

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chromosomes, Human, Pair 17 / Breast Neoplasms / Genes, erbB-2 / Gene Dosage / Comparative Genomic Hybridization Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Mod Pathol Journal subject: PATOLOGIA Year: 2009 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google